We operate in a globalized world where evidence, knowledge and information are rapidly diffused. When defining a global strategy, we always integrate the local level impact. While we operate at the local level, we remain conscious of the global vision. Our global presence in 4 continents and 11 countries allows our team to integrate global vision and local action to maximize the value potential.

We bridge evidence generation with value recognition. We are always vigilant when generating new evidence, ensuring compliance with gold level standards of the sciences as we realize the full value potential of health care interventions.

We are currently witnessing an inflection point in our field with the fast pace of innovation development on all fronts: biology, genetics, artificial intelligence, digital, policy etc. Our research is projected for this fast changing environment where today’s truth may not be entirely accurate tomorrow. Our team constantly operates in anticipation of disruptive landscapes, and changing decision frameworks required to secure contextualized value appreciation.

As we operate in a very dynamic environment, which is constantly evolving, we provide high flexibility in order to meet evolving expectations. As the degree of scientific requirements continuously increases and becomes stricter, Creativ-Ceutical continues to match this by delivering state of the art scientific rigor. Fortuitous events occur in our field and we constantly assess our deliverables to better anticipate and deliver under urgent deadlines. Our team successfully combines divergent requirements in order to generate value for clients when it is most needed.

We support our clients in critical and influential decision-making as we balance the full realization of their asset’s value and the maximization of patient access to new, innovative therapies. We are committed to tailoring custom, innovative solutions that deliver benefits and favorable outcomes for all stakeholders. We do so, above all, without sacrificing your product value as we integrate public health interest and help you deliver crucial patient care.

Our loyal customers appreciate the value and can attest to the impact of our technical and strategic deliverables on their business. We are acknowledged for the fairness and well-founded value of our services under all circumstances.

We have the internal expertise and skills to prepare and conduct all HEOR, P&R, and Market Access Projects needed for our clients.

We are creative, flexible, and strategic in our approach to do what is right for our client’s product and their company’s needs.

We have broad Market Access experience & expertise gained from projects for all major market & authority requirements in the EU, US and Japan.

• Cardiovascular Diseases
• Oncology
• Diagnostics
• Infectious Diseases/Vaccines
• Medical Procedures
• Central Nervous System Diseases

• Women’s Health
• Digital Health
• Metabolic Disorders
• Gene & Cell Therapies
• Rare Diseases

• Inflammation
• Immunology
• Respiratory
• Kidney Diseases
• Medical Devices